OBJECTIVE: To investigate secretor gene fucosyltransferase 2 (FUT2) polymorphism and secretor phenotype in relation to outcomes of prematurity. STUDY DESIGN: Study infants were ≤32 weeks gestational age. Secretor genotype was determined from salivary DNA. Secretor phenotype was measured with H antigen, the carbohydrate produced by secretor gene enzymes, in saliva samples collected on day 9 ± 5. The optimal predictive cutoff point in salivary H values was identified with Classification and Regression Tree analysis. Study outcomes were death, necrotizing enterocolitis (NEC, Bell's stage II/III), and confirmed sepsis. RESULTS: There were 410 study infants, 26 deaths, 30 cases of NEC, and 96 cases of sepsis. Analyzed by genotype, 13% of 95 infants who were non-secretors, 5% of 203 infants who were heterozygotes, and 2% of 96 infants who were secretor dominant died (P = .01). Analyzed by phenotype, 15% of 135 infants with low secretor phenotype died, compared with 2% of 248 infants with high secretor phenotype (predictive value = 76%, P < .001). Low secretor phenotype was associated (P < .05) with NEC, and non-secretor genotype was associated (P = .05) with gram negative sepsis. Secretor status remained significant after controlling for multiple clinical factors. CONCLUSIONS: Secretor genotype and phenotype may provide strong predictive biomarkers of adverse outcomes in premature infants.
OBJECTIVE: To investigate secretor gene fucosyltransferase 2 (FUT2) polymorphism and secretor phenotype in relation to outcomes of prematurity. STUDY DESIGN: Study infants were ≤32 weeks gestational age. Secretor genotype was determined from salivary DNA. Secretor phenotype was measured with H antigen, the carbohydrate produced by secretor gene enzymes, in saliva samples collected on day 9 ± 5. The optimal predictive cutoff point in salivary H values was identified with Classification and Regression Tree analysis. Study outcomes were death, necrotizing enterocolitis (NEC, Bell's stage II/III), and confirmed sepsis. RESULTS: There were 410 study infants, 26 deaths, 30 cases of NEC, and 96 cases of sepsis. Analyzed by genotype, 13% of 95 infants who were non-secretors, 5% of 203 infants who were heterozygotes, and 2% of 96 infants who were secretor dominant died (P = .01). Analyzed by phenotype, 15% of 135 infants with low secretor phenotype died, compared with 2% of 248 infants with high secretor phenotype (predictive value = 76%, P < .001). Low secretor phenotype was associated (P < .05) with NEC, and non-secretor genotype was associated (P = .05) with gram negative sepsis. Secretor status remained significant after controlling for multiple clinical factors. CONCLUSIONS: Secretor genotype and phenotype may provide strong predictive biomarkers of adverse outcomes in premature infants.
Authors: Pengwei Huang; Tibor Farkas; Weiming Zhong; Ming Tan; Scott Thornton; Ardythe L Morrow; Xi Jiang Journal: J Virol Date: 2005-06 Impact factor: 5.103
Authors: Dermot P B McGovern; Michelle R Jones; Kent D Taylor; Kristin Marciante; Xiaofei Yan; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Dror Berel; Carrie Derkowski; Deb Dutridge; Phil Fleshner; David Q Shih; Gil Melmed; Emebet Mengesha; Lily King; Sheila Pressman; Talin Haritunians; Xiuqing Guo; Stephan R Targan; Jerome I Rotter Journal: Hum Mol Genet Date: 2010-06-22 Impact factor: 6.150
Authors: H K F van Saene; N Taylor; S C Donnell; J Glynn; V L Magnall; Y Okada; N J Klein; A Pierro; D A Lloyd Journal: Eur J Clin Nutr Date: 2003-04 Impact factor: 4.016
Authors: Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman Journal: Annu Rev Nutr Date: 2014-05-15 Impact factor: 11.848
Authors: Rebecca L Currier; Daniel C Payne; Mary A Staat; Rangaraj Selvarangan; S Hannah Shirley; Natasha Halasa; Julie A Boom; Janet A Englund; Peter G Szilagyi; Christopher J Harrison; Eileen J Klein; Geoffrey A Weinberg; Mary E Wikswo; Umesh Parashar; Jan Vinjé; Ardythe L Morrow Journal: Clin Infect Dis Date: 2015-03-05 Impact factor: 9.079
Authors: Zhuo-Teng Yu; Ceng Chen; David E Kling; Bo Liu; John M McCoy; Massimo Merighi; Matthew Heidtman; David S Newburg Journal: Glycobiology Date: 2012-10-01 Impact factor: 4.313
Authors: Maria Lorna A De Leoz; Stephanie C Gaerlan; John S Strum; Lauren M Dimapasoc; Majid Mirmiran; Daniel J Tancredi; Jennifer T Smilowitz; Karen M Kalanetra; David A Mills; J Bruce German; Carlito B Lebrilla; Mark A Underwood Journal: J Proteome Res Date: 2012-08-28 Impact factor: 4.466